iRGD-CPT is an iRGD-camptothecin conjugate covalently linked via a heterobifunctional linker. It exhibits anticancer activity both in vivo and in vitro and can be utilized in colon cancer research.
Formula:
C75H100N18O27S3
Target:
Integrin|||DNA/RNA Synthesis|||Topoisomerase
* VAT and and shipping costs not included. Errors and price changes excepted